| Financial Year |
March 31 2023 |
| Monetary Funds |
2,912,300,596.82 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
403,044,492.28 |
| Accounts Receivable |
1,550,435,328.99 |
| Advances to Suppliers |
12,433,599.08 |
| Other Receivables |
15,607,610.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,041,850,237.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,168,272.51 |
| Total Current Assets |
6,061,257,280.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
38,483,539.37 |
| Investment Properties |
1,937,870.42 |
| Fixed Assetes |
71,583,486.37 |
| Under-construction Projects |
112,783,148.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
472,965,305.33 |
| R&D expenses |
-- |
| Goodwill |
12,924,354.06 |
| Long-Term Deferred and Prepaid Expenses |
71,297,070.47 |
| Deferred Income Tax Assets |
58,246,921.29 |
| Other Non-Current Assets |
6,955,522.22 |
| Sub-Total of Non-Current Assets |
960,247,345.89 |
| Total Assets |
7,021,504,626.41 |
| Short-Term Loans |
3,957,076.21 |
| Trading Financial liabilities |
-- |
| Notes Payable |
189,899,682.51 |
| Accounts Payable |
462,392,186.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
209,672,692.19 |
| Taxes Payable |
40,905,804.66 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,256,391.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
43,778,539.11 |
| Other Current Liabilities |
133,143,940.55 |
| Sub-Total of Current Liabilities |
1,135,409,582.66 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
23,104,543.56 |
| Deferred Income Tax Liabilities |
3,745,044.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
104,198,052.62 |
| Total Liabilities |
1,239,607,635.28 |
| Paid-In Capital(Or Share Stock) |
420,000,000.00 |
| Capital Surplus |
4,070,153,929.23 |
| Surplus Reserve |
145,856,012.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,143,683,489.16 |
| Minority Stockholder's Interest |
2,010,278.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,779,886,712.37 |
| Owner's Equity（Stockholder's Equity） |
5,781,896,991.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,021,504,626.41 |
